“Scott’s attention to detail and expertise is something any team needs. ”
About
Pioneering regulatory affairs executive with 15+ years of dedicated experience in orphan…
Experience & Education
-
The Price of Presence
View Scott N.’s full experience
See their title, tenure and more.
or
Publications
-
A new vaccine approach and convalescent plasma until its development
OSF Preprints
See publicationWe have outlined the idea of creating a synthetic standardized convalescent plasma with assigned neutralization capacity and a vaccine strategy using a multipeptide approach targeting the mucosal immune system.
-
FDA Regulatory Affairs, 3rd Edition
CRC Press
See publicationAuthor of Chapter 7: The Development of Orphan Drugs
-
What the orphan drug act has done lately for children with rare diseases: a 10-year analysis.
See publicationThorat C, Xu K, Freeman SN, Bonnel RA, Joseph F, Phillips MI, Imoisili MA.
Pediatrics. 2012 Mar;129(3):516-21. -
RhoBTB2 (DBC2) comes of age as a multifunctional tumor suppressor.
See publicationFreeman SN, and Cress WD.
Cancer Biology and Therapy. 2010 Dec 28;10(11). -
The impact of the Orphan Drug Act on the development and advancement of neurological products for rare diseases: a descriptive review.
See publicationBurke KA, Freeman SN, Imoisili MA, Coté TR.
Clin Pharmacol Ther. 2010 Oct;88(4):449-53. -
The Orphan Drug Act and the development of stem cell-based products for rare diseases.
See publicationFreeman SN, Burke KA, Imoisili MA, Coté TR.
Cell Stem Cell. 2010 Sep 3;7(3):283-7. -
RRM1 (ribonucleotide reductase M1).
See publicationFreeman SN, Bepler G.
Atlas Genet Cytogenet Oncol Haematol. June 2009. -
RhoBTB2 (DBC2) is a mitotic E2F1 target gene with a novel role in apoptosis.
See publicationFreeman SN, Ma Y, Cress WD.
J Biol Chem. 2008 Jan 25;283(4):2353-62. -
Re: Prognostic significance of a short sequence insertion in the MCL-1 promoter in chronic lymphocytic leukemia.
See publicationFreeman SN, Bepler G, Haura E, Sutphen R, Cress WD.
J Natl Cancer Inst. 2005 Jul 20;97(14):1088-9. -
E2F4 deficiency promotes drug-induced apoptosis.
See publicationMa Y, Freeman SN, Cress WD.
Cancer Biol Ther. 2004 Dec;3(12):1262-9.
Languages
-
German
Elementary proficiency
-
English
Native or bilingual proficiency
Recommendations received
1 person has recommended Scott N.
Join now to viewOther similar profiles
Explore collaborative articles
We’re unlocking community knowledge in a new way. Experts add insights directly into each article, started with the help of AI.
Explore More